title: Propofol combined with lorazepam for severe poly substance misuse and withdrawal states in intensive care unit: a case series and review.
abstract: A safe, rapid, and effective way to detoxify patients from substance misuse is important in facilitating further treatment of their psychiatric or substance use disorder. This paper discusses the treatment of acute withdrawal from polysubstance misuse in three patients in the intensive care unit setting using combined sedation with a benzodiazepine, lorazepam, and a general anaesthetic, propofol. Lorazepam alone was not effective in massive doses in these cases. The advantages and mechanism of action of using multiple agents to control refractory symptoms is discussed.
authors.affiliation: Long Island College Hospital, Brooklyn, NY, USA. kathirvels@yahoo.com <kathirvels@yahoo.com>
authors.forename: K
authors.initials: K
authors.lastname: Subramaniam
authors.forename: R M
authors.initials: RM
authors.lastname: Gowda
authors.forename: K
authors.initials: K
authors.lastname: Jani
authors.forename: W
authors.initials: W
authors.lastname: Zewedie
authors.forename: R
authors.initials: R
authors.lastname: Ute
mesh_terms: D000328:Adult; D018686:Anesthetics, Intravenous / Q000627:therapeutic use*; D003422:Critical Care / Q000379:methods; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D008140:Lorazepam / Q000627:therapeutic use*; D008297:Male; D015742:Propofol / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*
chemical_list: D018686:Anesthetics, Intravenous; D006993:Hypnotics and Sedatives; D008140:Lorazepam; D015742:Propofol